Pegassist
Where Patients Matter
Type a Question Go
Patient Home Page
Welcome to Pegassist.com for Healthcare Professionals
Pegassist makes it easier for you to start and maintain your patients on treatment.

The following are Hepatitis C and HCV/HIV materials and designed to enhance your efforts and maximize your time with your patients.

Pegassist® Enhances Your Efforts, Maximizes Your Time tri-fold brochure

Pegassist® Enhances Your Efforts, Maximizes Your Time tri-fold brochure
--This visually-focused foldout brochure provides a small image of each Pegassist piece, service, or resource, with brief descriptions and their intended use during the assessment phase, treatment initiation, or maintenance. It provides an overview of the materials available to you to help inform patients, dispel common misconceptions, facilitate dialog, build motivation, and encourage compliance throughout assessment and treatment.

Available in English
Hepatitis C: What You Should Know brochure

Hepatitis C: What You Should Know brochure
-- This comprehensive brochure helps you educate patients about hepatitis C. It answers many questions patients have and supplements your teaching. It also provides more detailed answers to the questions presented on the patient assessment tool. Patients can share this brochure with family and friends.

Available in English, Spanish, Chinese, Korean, Russian, and Vietnamese
Q&A: Answers to your common questions

Q&A: Answers to your common questions
--Answers common questions about hep C and treatment with PEGASYS® (Peginterferon alfa-2a) and COPEGUS (Ribavirin, USP), and the importance of staying on therapy

Available in English, Spanish, Chinese, Korean, Russian, and Vietnamese
Hepatitis C—Life During Treatment brochure

Hepatitis C—Life During Treatment brochure
-- This brochure supplements your discussions on treatment, side effects, and success rates. It also helps to motivate patients, manage their expectations, prepare for issues that may arise and encourages them to seek support from healthcare providers, friends and family and the Pegassist program.

Available in English, Spanish, Chinese, Korean, Russian, and Vietnamese
Self-injection guide for Pegasys

Self-injection guide for Pegasys
--Detailed instructions on proper procedure for injecting PEGASYS

Available in English

 

What you need to know about hepatitis C when you have HIV

What you need to know about hepatitis C when you have HIV
--
Provides basic information about the virus, how to get tested, and how to avoid transmission
--Discusses the importance of a healthy liver, how hep C treatment may affect HIV, treatment options, and support with Pegassist

Available in English and Spanish
Fighting hepatitis C when you have HIV

Fighting hepatitis C when you have HIV
-- Answers questions about how treatment for hep C affects HIV and CD4+ counts
-- Answers common questions about hep C and treatment with PEGASYS and COPEGUS, and the importance of staying on therapy

Available in English and Spanish
Hepatitis C-What Do You Believe?

Hepatitis C—What Do You Believe?
--This handout can be provided to patients while they are in the waiting room or are waiting to be seen. It will help you evaluate your patients' beliefs and identify their misperceptions about hepatitis C and treatment. The front includes a quiz for the patient to take, while the back helps you address facts about hepatitis C and its treatment with the patient. Also located on the back is a readiness assessment to help you gauge the patient's interest and motivation in beginning treatment.

Available in English, Spanish, Chinese, Korean, Russian, and Vietnamese
A Guide for family and friends

When You Know Someone Who Has Hepatitis C handout
-- This handout is meant for patients to share with their family or friends. It covers facts about hepatitis C, how spreading hepatitis C can be prevented and how family and friends can support the person who is undergoing treatment.

Available in English, Spanish, Chinese, Korean, Russian, and Vietnamese
Hep C Tests handout

Hep C Tests handout
-- This informative patient handout explains the usual blood tests and diagnostic procedures a patient undergoes once diagnosed with hepatitis C. Graphics show the location of the liver in the body and illustrate liver damage to help you describe what you are evaluating when performing these tests and procedures.

Available in English, Spanish, Chinese, Korean, Russian, and Vietnamese
 
Side-effect sheets

Side-effect sheets
--Discusses steps patients can take:

Nausea - English and Spanish
Hair Loss - English and Spanish
Depression - English and Spanish
Fatigue/Insomnia - English and Spanish
Flu-like Symptoms - English and Spanish
Skin Problems - English and Spanish

Safety Information

What is PEGASYS?

PEGASYS is a medicine used to treat some adults who have hepatitis C and signs of liver damage. PEGASYS works to reduce the amount of virus in your blood, helping your body fight the virus.

PEGASYS® (Peginterferon alfa-2a), like other alpha interferons, can cause fatal or make life-threatening problems worse (like mental, immune system, heart, liver, lung, intestinal and infections). Your doctor should monitor you during regular visits. If you show signs or symptoms of these conditions, your doctor may stop your medication. In most patients, these conditions get better after you stop taking PEGASYS (see medication guide for more information and warnings).

What is COPEGUS?

COPEGUS is a medicine that works by slowing down the growth of the virus. COPEGUS should be taken with PEGASYS to fight the virus. Do not take COPEGUS by itself.

COPEGUS® (Ribavirin, USP) can be extremely harmful and cause birth defects in an unborn baby. Female patients and the female partners of male patients should avoid getting pregnant. Ribavirin is known to cause anemia (low red blood cells), which can make heart disease worse. Also, ribavirin can harm your DNA and possibly cause cancer (see medication guide for more information and warnings).

Who should not take PEGASYS and COPEGUS?

Do not take PEGASYS alone or with COPEGUS if:

  • You are pregnant or your partner is pregnant
  • You or your partner plans to get pregnant during therapy or within 6 months after treatment ends
  • You are breastfeeding
  • You have hepatitis caused by your immune system (autoimmune hepatitis)
  • You have unstable or severe liver disease before or during treatment
  • You are allergic to alpha interferons or any of the ingredients in PEGASYS and COPEGUS
  • You have abnormal red blood cells (caused by conditions like sickle-cell anemia or thalassemia major)

What if I am pregnant or thinking about having a baby?

If you are a woman who could get pregnant, you must take pregnancy tests before, during and for 6 months after treatment ends to make sure you are not pregnant.

During treatment and for 6 months after treatment, female and male patients must:

  • Use two forms of birth control (one being a condom with spermicide)
  • Tell your doctor right away if you or your partner becomes pregnant. You or
    your doctor should also call the Ribavirin Pregnancy Registry at 1-800-593-2214

What medication should I avoid when I am taking PEGASYS and COPEGUS?

You should not take didanosine with COPEGUS. Talk to your doctor about all medications that you are taking.

What are the possible side effects?

The most common side effects of PEGASYS and COPEGUS are:

  • Flu-like symptoms (including fever, chills, muscle aches, joint pain, headaches)
  • Tiredness
  • Upset stomach (like nausea, taste changes, diarrhea)
  • Blood sugar problems (may lead to diabetes)
  • Skin problems (like rash, dry or itchy skin, redness and swelling at injection site)
  • Hair loss (temporary)
  • Trouble sleeping

The most serious side effects of PEGASYS and COPEGUS are:

  • Risks to pregnancies
  • Mental health problems (such as irritability, depression, anxiety, aggressiveness, trouble with drug addiction or overdose, thoughts about suicide, suicide attempts, suicide and thoughts about homicide)
  • Blood problems (like a drop in blood cells leading to increased risk for infections, bleeding and/or heart or circulatory problems)
  • Infections (which sometimes cause death)
  • Lung problems (like trouble breathing, pneumonia)
  • Eye problems (like blurred vision, loss of vision)
  • Autoimmune problems (such as psoriasis, thyroid problems)
  • Heart problems (including chest pain and, rarely, a heart attack)
  • Liver problems (rarely, liver function worsens). Patients with both the hepatitis C virus and HIV can have an increased chance of having liver failure during PEGASYS treatment. Change in a blood test that measures liver inflammation occurs more often in patients with hepatitis B. If you have a rise in this blood test you may need to be watched more closely with additional blood tests.

Tell your doctor immediately if you think you or your partner may be pregnant or if any of these symptoms occur.

This information does not take the place of talking to your healthcare professional about your medical condition or your treatment.

Please see the medication guides and complete product information for PEGASYS and COPEGUS.

 

THIS SITE INTENDED FOR U.S. AUDIENCES ONLY

For more information about PEGASYS, contact your physician or other healthcare professional.

Roche
Copyright © 2003-2008 Hoffmann-La Roche Inc. All rights reserved. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and PRIVACY Statement. Because Pegassist.com offers some unique features and options, Roche provides additional protection tailored to those items. Click here to read Additional Details about your Privacy.
   
eHealthcare Leadership Awards 2004 Winner, Gold Award: Best Care/Disease Management Site Brought to you by the makers of PEGASYS® (Peginterferon alfa-2a)
Gold Award:
Best Care/Disease
Management Site